JP7353663B2 - Ｇａｂａａ受容体リガンド - Google Patents
Ｇａｂａａ受容体リガンド Download PDFInfo
- Publication number
- JP7353663B2 JP7353663B2 JP2021514324A JP2021514324A JP7353663B2 JP 7353663 B2 JP7353663 B2 JP 7353663B2 JP 2021514324 A JP2021514324 A JP 2021514324A JP 2021514324 A JP2021514324 A JP 2021514324A JP 7353663 B2 JP7353663 B2 JP 7353663B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- rats
- pruritus
- treatment
- gaba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18194297.0 | 2018-09-13 | ||
| EP18194297 | 2018-09-13 | ||
| PCT/EP2019/074465 WO2020053377A1 (en) | 2018-09-13 | 2019-09-13 | A gabaa receptor ligand |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022500445A JP2022500445A (ja) | 2022-01-04 |
| JPWO2020053377A5 JPWO2020053377A5 (https=) | 2022-10-17 |
| JP2022500445A5 JP2022500445A5 (https=) | 2022-10-17 |
| JP7353663B2 true JP7353663B2 (ja) | 2023-10-02 |
Family
ID=63579205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514324A Active JP7353663B2 (ja) | 2018-09-13 | 2019-09-13 | Ｇａｂａａ受容体リガンド |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US11396510B2 (https=) |
| EP (1) | EP3849976B1 (https=) |
| JP (1) | JP7353663B2 (https=) |
| KR (1) | KR102712565B1 (https=) |
| CN (1) | CN112714765B (https=) |
| AU (1) | AU2019338236B2 (https=) |
| BR (1) | BR112021004661A2 (https=) |
| CA (1) | CA3110283A1 (https=) |
| DK (1) | DK3849976T3 (https=) |
| EA (1) | EA202190717A1 (https=) |
| ES (1) | ES2935705T3 (https=) |
| FI (1) | FI3849976T3 (https=) |
| HR (1) | HRP20230067T1 (https=) |
| HU (1) | HUE060943T2 (https=) |
| IL (1) | IL281335B2 (https=) |
| LT (1) | LT3849976T (https=) |
| MX (1) | MX2021003010A (https=) |
| PH (1) | PH12021550299A1 (https=) |
| PL (1) | PL3849976T3 (https=) |
| PT (1) | PT3849976T (https=) |
| SG (1) | SG11202101360VA (https=) |
| SI (1) | SI3849976T1 (https=) |
| WO (1) | WO2020053377A1 (https=) |
| ZA (1) | ZA202100976B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4322955A1 (en) | 2021-04-16 | 2024-02-21 | Saniona A/S | A gaba receptor modulator for use in the treatment of pain |
| WO2025056751A1 (en) * | 2023-09-15 | 2025-03-20 | Saniona A/S | A gaba receptor modulator for use in the treatment of absence seizures |
| CN121793969A (zh) * | 2023-09-15 | 2026-04-03 | 萨尼奥纳有限责任公司 | 一种用于治疗与睡眠纺锤波缺陷相关的疾病的gaba受体调节剂 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003508530A (ja) | 1999-09-07 | 2003-03-04 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体のリガンドとなるイミダゾ−ピリジン誘導体 |
| WO2003087099A1 (en) | 2002-04-11 | 2003-10-23 | Merck Sharp & Dohme Limited | Imidazo-pyridine derivatives as ligands for gaba receptors |
| WO2003086406A1 (en) | 2002-04-11 | 2003-10-23 | Merck Sharp & Dohme Limited | Imidazo-pyridine derivatives as ligands for gaba receptors |
| JP2005531582A (ja) | 2002-05-24 | 2005-10-20 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体のリガンドとしてのイミダゾ−ピリジン誘導体 |
| JP2009530353A (ja) | 2006-03-24 | 2009-08-27 | ノイロサーチ アクティーゼルスカブ | ベンズイミダゾール誘導体、及びｇａｂａａ受容体複合体をモジュレートするためのその使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU675484B2 (en) | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
| GB9702524D0 (en) | 1997-02-07 | 1997-03-26 | Merck Sharp & Dohme | Therapeutic agents |
| GB9813576D0 (en) | 1998-06-24 | 1998-08-19 | Merck Sharp & Dohme | Therapeutic agents |
| JP2002535407A (ja) | 1999-01-27 | 2002-10-22 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体のリガンドとしてのトリアゾロピリダジン誘導体 |
| WO2004087690A2 (en) | 2003-04-03 | 2004-10-14 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
| TW201029986A (en) | 2008-11-14 | 2010-08-16 | Neurosearch As | Novel compounds |
| SG11201806393QA (en) | 2016-01-27 | 2018-08-30 | Univ Zuerich | Use of gabaa receptor modulators for treatment of itch |
-
2019
- 2019-09-13 KR KR1020217006185A patent/KR102712565B1/ko active Active
- 2019-09-13 IL IL281335A patent/IL281335B2/en unknown
- 2019-09-13 BR BR112021004661-5A patent/BR112021004661A2/pt unknown
- 2019-09-13 AU AU2019338236A patent/AU2019338236B2/en active Active
- 2019-09-13 SI SI201930443T patent/SI3849976T1/sl unknown
- 2019-09-13 EP EP19765747.1A patent/EP3849976B1/en active Active
- 2019-09-13 JP JP2021514324A patent/JP7353663B2/ja active Active
- 2019-09-13 PT PT197657471T patent/PT3849976T/pt unknown
- 2019-09-13 US US17/272,971 patent/US11396510B2/en active Active
- 2019-09-13 CA CA3110283A patent/CA3110283A1/en active Pending
- 2019-09-13 WO PCT/EP2019/074465 patent/WO2020053377A1/en not_active Ceased
- 2019-09-13 HR HRP20230067TT patent/HRP20230067T1/hr unknown
- 2019-09-13 LT LTEPPCT/EP2019/074465T patent/LT3849976T/lt unknown
- 2019-09-13 CN CN201980059446.2A patent/CN112714765B/zh active Active
- 2019-09-13 SG SG11202101360VA patent/SG11202101360VA/en unknown
- 2019-09-13 HU HUE19765747A patent/HUE060943T2/hu unknown
- 2019-09-13 DK DK19765747.1T patent/DK3849976T3/da active
- 2019-09-13 PL PL19765747.1T patent/PL3849976T3/pl unknown
- 2019-09-13 MX MX2021003010A patent/MX2021003010A/es unknown
- 2019-09-13 EA EA202190717A patent/EA202190717A1/ru unknown
- 2019-09-13 ES ES19765747T patent/ES2935705T3/es active Active
- 2019-09-13 FI FIEP19765747.1T patent/FI3849976T3/fi active
-
2021
- 2021-02-10 PH PH12021550299A patent/PH12021550299A1/en unknown
- 2021-02-12 ZA ZA2021/00976A patent/ZA202100976B/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003508530A (ja) | 1999-09-07 | 2003-03-04 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体のリガンドとなるイミダゾ−ピリジン誘導体 |
| WO2003087099A1 (en) | 2002-04-11 | 2003-10-23 | Merck Sharp & Dohme Limited | Imidazo-pyridine derivatives as ligands for gaba receptors |
| WO2003086406A1 (en) | 2002-04-11 | 2003-10-23 | Merck Sharp & Dohme Limited | Imidazo-pyridine derivatives as ligands for gaba receptors |
| JP2005531582A (ja) | 2002-05-24 | 2005-10-20 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体のリガンドとしてのイミダゾ−ピリジン誘導体 |
| JP2009530353A (ja) | 2006-03-24 | 2009-08-27 | ノイロサーチ アクティーゼルスカブ | ベンズイミダゾール誘導体、及びｇａｂａａ受容体複合体をモジュレートするためのその使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022500445A (ja) | 2022-01-04 |
| AU2019338236A1 (en) | 2021-05-20 |
| EP3849976B1 (en) | 2022-10-26 |
| US11396510B2 (en) | 2022-07-26 |
| DK3849976T3 (da) | 2023-01-23 |
| IL281335B1 (en) | 2024-03-01 |
| IL281335A (en) | 2021-04-29 |
| EA202190717A1 (ru) | 2021-09-22 |
| LT3849976T (lt) | 2023-02-10 |
| CN112714765A (zh) | 2021-04-27 |
| PH12021550299A1 (en) | 2021-10-25 |
| HUE060943T2 (hu) | 2023-04-28 |
| PT3849976T (pt) | 2023-01-13 |
| KR102712565B1 (ko) | 2024-10-02 |
| FI3849976T3 (fi) | 2023-02-19 |
| WO2020053377A1 (en) | 2020-03-19 |
| SG11202101360VA (en) | 2021-03-30 |
| PL3849976T3 (pl) | 2023-02-27 |
| CN112714765B (zh) | 2023-06-30 |
| IL281335B2 (en) | 2024-07-01 |
| CA3110283A1 (en) | 2020-03-19 |
| US20210332042A1 (en) | 2021-10-28 |
| EP3849976A1 (en) | 2021-07-21 |
| MX2021003010A (es) | 2021-05-27 |
| ES2935705T3 (es) | 2023-03-09 |
| SI3849976T1 (sl) | 2023-03-31 |
| ZA202100976B (en) | 2022-08-31 |
| HRP20230067T1 (hr) | 2023-03-17 |
| KR20210061338A (ko) | 2021-05-27 |
| AU2019338236B2 (en) | 2025-01-09 |
| BR112021004661A2 (pt) | 2021-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7082186B2 (ja) | プリドピジンによる筋萎縮性側索硬化症の治療方法 | |
| De Witt et al. | Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors | |
| US12551474B2 (en) | Use of pridopidine for the treatment of fragile X syndrome | |
| JP7514534B2 (ja) | 認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法 | |
| JP7353663B2 (ja) | Ｇａｂａａ受容体リガンド | |
| KR20200098536A (ko) | Dux4 발현과 관련된 질병의 치료를 위한 화합물 | |
| JP2020513005A (ja) | Ｃｃｒ３阻害剤を用いて、加齢性機能障害を治療するための方法及び組成物 | |
| MX2015004162A (es) | Usos novedosos. | |
| BR112020010120A2 (pt) | compostos derivados de pirimidina e sua composição farmacêutica | |
| EA042675B1 (ru) | Лиганд рецептора гамк-а | |
| HK40057209A (en) | A gabaa receptor ligand | |
| HK40057209B (en) | A gabaa receptor ligand | |
| Botsula et al. | New pharmaceutical materials with analgesic activity based on 1, 2, 3-triazolo-1, 4-benzodiazepine | |
| AU2015363757B2 (en) | Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists | |
| Schwartz | S. 27.01 The dopamine D3 receptor as a therapeutic target |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220909 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220909 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220912 |
|
| TRDD | Decision of grant or rejection written | ||
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230810 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230815 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230912 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7353663 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |